GRADALIS, INC.

Profile

Company Names

GRADALIS, INC.

Addresses

2545 GOLDEN BEAR DRIVE, SUITE 110, CARROLLTON, TX 75006

8333 DOUGLAS AVENUE, SUITE 1600, DALLAS, TX 75225

Phone Numbers

(214) 442-8100
(214) 307-8200

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY, PHARMACEUTICALS

Year Incorporated:

2014

State Incorporated:

DELAWARE

Total Amount Raised:

$56,661,167.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2025-06-05 
$12,725,000.00 
$30,000,000.00 
$17,275,000.00 
Debt 
1
2018-03-16 
$43,936,167.00 
$55,000,000.00 
$11,063,833.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
JOSEPH 
F. 
BERRY 
DIRECTOR
AM3 HOLDING CORP.   |  COREALPHA PRIVATE EQUITY PARTNERS III, L.P.   |  AM3 PINNACLE CORP   |  COREALPHA PRIVATE EQUITY PARTNERS PARTNERSHIP FUND IV, L.P.   |  COREALPHA PRIVATE EQUITY PARTNERS CO-INVESTMENT FUND IV, L.P.   |  COREALPHA PRIVATE EQUITY PARTNERS PARTNERSHIP FUND IV (CAYMAN), L.P.   |  COREALPHA PRIVATE EQUITY PARTNERS CO-INVESTMENT FUND IV (CAYMAN), L.P.   |  WP PRIVATE DEBT PARTNERSHIP FUND III LP   |  WP PRIVATE DEBT CO-INVESTMENT FUND III LP   |  WP PRIVATE DEBT PARTNERSHIP FUND III (CAYMAN), L.P.   |  WP PRIVATE DEBT CO-INVESTMENT FUND III (CAYMAN), L.P.   |  COREALPHA PRIVATE EQUITY PARTNERS PARTNERSHIP FUND V, L.P.   |  COREALPHA PRIVATE EQUITY PARTNERS CO-INVESTMENT FUND V, L.P.   |  COREALPHA PRIVATE EQUITY PARTNERS PARTNERSHIP FUND V (CAYMAN), L.P.   |  COREALPHA PRIVATE EQUITY PARTNERS CO-INVESTMENT FUND V (CAYMAN), L.P.   |  HC INNOVATIVE PARTNERS, LP   |  USB F+F INVESTORS LLC   |  WP EXPLORER 3 LP   |  WP COREALPHA VI LP   |  GRADALIS, INC.
ERNEST 
 
BOGNAR 
EXECUTIVE OFFICER
GRADALIS, INC.
JOE 
C. 
CUNNINGHAM 
DIRECTOR
GRADALIS, INC.
JOE 
 
CUNNINGHAM, M.D. 
DIRECTOR
GRADALIS, INC.
MARK 
 
EARLY 
EXECUTIVE OFFICER
GRADALIS, INC.
HARRY 
R. 
JACOBSON 
DIRECTOR
MEDSOLUTIONS HOLDINGS, INC.   |  BIONUMERIK PHARMACEUTICALS, INC.   |  CELONOVA BIOSCIENCES, INC.   |  TRI-STAR TECHNOLOGY FUND II, L.P.   |  CITIZENGINE, INC.   |  MINDCARE SOLUTIONS GROUP, INC.   |  OCCUSYSTEM SERVICES, INC.   |  GRADALIS, INC.
HARRY 
 
JACOBSON, M.D. 
DIRECTOR
GRADALIS, INC.
ROBERT 
 
LANDIN 
DIRECTOR
GRADALIS, INC.   |  MREI VI BLOCKER FEEDER, LP   |  MILESTONE REAL ESTATE INVESTORS VI, LP   |  MREI VI REIT FEEDER A, LP   |  MREI VI REIT FEEDER C, LP   |  MREI VI REIT FEEDER D, LP   |  MREI VI REIT B, LP   |  MREI VI REIT C, LP   |  MREI VI REIT A, LP   |  MREI VI REIT D, LP   |  MREI VI BLOCKER FEEDER A, LP   |  MREI VI REIT FEEDER B, LP   |  MREI VI REIT FEEDER E, LP   |  MREI VI BLOCKER FEEDER B, LP   |  MREI VI REIT E, LP
ROBERT 
P. 
LANDIN 
DIRECTOR
MILESTONE REAL ESTATE INVESTORS III, LP   |  MREI III INVESTORS, LP   |  MILESTONE III REIT, LLC   |  MREI GP III, LLC   |  G-CON MANUFACTURING, INC.   |  MILESTONE MULTIFAMILY INVESTORS LP   |  MREI IV INVESTORS, LP   |  MILESTONE REAL ESTATE INVESTORS IV, LP   |  MREI IV REIT FEEDER A, LP   |  MREI IV REIT FEEDER B, LP   |  MREI IV BLOCKER FEEDER, LP   |  MREI IV REIT FEEDER C, LP   |  MILESTONE REAL ESTATE INVESTORS V, LP   |  MREI V INVESTORS, LP   |  MREI V REIT FEEDER A, LP   |  MREI V REIT FEEDER C, LP   |  MREI V REIT FEEDER D, LP   |  MREI V BLOCKER FEEDER C, LP   |  MREI V REIT FEEDER B, LP   |  MREI V REIT BLOCKER A, LP   |  GRADALIS, INC.
RENEE 
 
LARSON 
EXECUTIVE OFFICER
GRADALIS, INC.
THOMAS 
 
LYLES 
DIRECTOR
CARDIOVASCULAR CARE GROUP, INC.   |  G-CON MANUFACTURING, INC.   |  GRADALIS, INC.
JOHN 
 
NEMUNAITIS 
EXECUTIVE OFFICER, DIRECTOR
GRADALIS, INC.
JOHN 
 
NEMUNAITIS, M.D. 
EXECUTIVE OFFICER, DIRECTOR
GRADALIS, INC.
SCOTT 
 
SEAMAN 
DIRECTOR
GRAMERCY EMERGING MARKETS LTD   |  GRAMERCY ARGENTINA OPPORTUNITY FUND LTD   |  GRAMERCY DISTRESSED ARGENTINA FUND, LTD.   |  GRAMERCY DISTRESSED OPPORTUNITY ONSHORE FUND LLC   |  GRAMERCY DISTRESSED OPPORTUNITY OFFSHORE FUND LTD.   |  GRAMERCY EMERGING MARKETS ALPHA LLC   |  GRAMERCY EMERGING MARKETS ALPHA LTD   |  GRAMERCY MASTER FUND LLC   |  GRAMERCY HIGH YIELD CORPORATE EMERGING MARKETS DEBT FUND LLC   |  GRAMERCY EMD ALLOCATION FUND LLC   |  GRAMERCY DYNAMIC EMERGING EQUITY FUND LLC   |  GRAMERCY CORPORATE EMERGING MARKETS DEBT FUND LLC   |  GRAMERCY EMD ALLOCATION FUND LTD   |  GRAMERCY EMERGING MARKETS EQUITIES LLC   |  GRAMERCY GLOBAL EQUITIES FUND LLC   |  GRAMERCY DISTRESSED OPPORTUNITY FUND II, L.P.   |  GRAMERCY EMERGING MARKETS EQUITIES FUND LLC   |  GRAMERCY CREDIT OPPORTUNITIES FUND LLC   |  GRAMERCY DISTRESSED ARGENTINA MASTER FUND II   |  GRAMERCY OPPORTUNITY FUND - UFCW NO CA PARTNERS SP   |  GRAMERCY DISTRESSED ARGENTINA OFFSHORE FUND II   |  GRAMERCY SPECIAL OPPORTUNITY FUND - PALM SP   |  GRAMERCY SPECIAL OPPORTUNITY FUND - SOCA SP   |  GRAMERCY SPECIAL OPPORTUNITY FUND - NOCA SP   |  GRAMERCY SPECIAL OPPORTUNITY FUND - MA-11 SP   |  GRAMERCY SPECIAL OPPORTUNITY FUND - 1839 SP   |  GRAMERCY SPECIAL OPPORTUNITY FUND - MAG SP   |  GRAMERCY SPECIAL OPPORTUNITY FUND - SOIILP SP   |  GRAMERCY SPECIAL OPPORTUNITY FUND - CREDITLP SP   |  GRAMERCY SPECIAL OPPORTUNITY FUND - DIVII SP   |  GRAMERCY SPECIAL OPPORTUNITY FUND - WP SP   |  GRAMERCY SPECIAL OPPORTUNITY FUND - DIVLP SP   |  GRAMERCY DISTRESSED OPPORTUNITY FUND III, L.P.   |  GRAMERCY DISTRESSED ARGENTINA PRIVATE FUND III, L.P.   |  GRADALIS, INC.   |  GRAMERCY CAPITAL SOLUTIONS FUND, L.P.   |  GRAMERCY VENEZUELA SPECIAL SITUATIONS FUND, L.P.   |  GRAMEX INVESTMENT HOLDINGS LLC   |  CATASTROPHE RELIEF HOLDINGS, L.P.   |  GRAMERCY CAPITAL SOLUTIONS FUND II, L.P.   |  GRAMERCY SPECIAL SITUATIONS OPPORTUNITY I LP   |  GRAMERCY CAPITAL SOLUTIONS FUND III, L.P.
DAVID 
 
SHANAHAN 
EXECUTIVE OFFICER, DIRECTOR
GRADALIS, INC.   |  G-CON MANUFACTURING, INC.
DAVID 
M. 
SHANAHAN 
EXECUTIVE OFFICER, DIRECTOR
G-CON MANUFACTURING, INC.   |  GRADALIS, INC.
GLADICE 
 
WALLRAVEN 
EXECUTIVE OFFICER
GRADALIS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2025-06-12
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2025-06-05 
2018-04-02
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2018-03-16 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#